MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹13 Cr | ₹14 Cr | ₹16 Cr | ₹19 Cr | ₹15 Cr |
What is the latest Total Current Liabilities ratio of MERCURY LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹13 Cr |
Mar2023 | ₹14 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹15 Cr |
How is Total Current Liabilities of MERCURY LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | -8.69 | |
Mar2023 | ₹14 Cr | -9.98 | |
Mar2022 | ₹16 Cr | -16.39 | |
Mar2021 | ₹19 Cr | 25.02 | |
Mar2020 | ₹15 Cr | - |
Compare Total Current Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹113.3 Cr | -3.5% | -9.4% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,346.0 Cr | -2.4% | -6.8% | 50.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,494.0 Cr | -3.3% | -6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹121,151.0 Cr | -5.8% | -4% | 21% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,300.0 Cr | -4.4% | -8.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,402.2 Cr | -1.1% | -6% | 54.5% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -3.5% |
-9.4% |
19.2% |
SENSEX | -2.5% |
-5.2% |
19.5% |
You may also like the below Video Courses